JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB74154

Anti-Ret (phospho Y1015) antibody

Be the first to review this product! Submit a review

|

(5 Publications)

Rabbit Polyclonal RET phospho Y1015 antibody. Suitable for WB and reacts with African green monkey samples. Cited in 5 publications. Immunogen corresponding to Synthetic Peptide within Human RET phospho Y1015.

View Alternative Names

CDHF12, CDHR16, PTC, RET51, RET, Proto-oncogene tyrosine-protein kinase receptor Ret, Cadherin family member 12, Proto-oncogene c-Ret

1 Images
Western blot - Anti-Ret (phospho Y1015) antibody (AB74154)
  • WB

Unknown

Western blot - Anti-Ret (phospho Y1015) antibody (AB74154)

All lanes:

Western blot - Anti-Ret (phospho Y1015) antibody (ab74154) at 1/500 dilution

Lane 1:

Extracts from COS7 cells treated with EGF (200ng/ml, 30mins) at 30 µg

Lane 2:

Extracts from COS7 cells treated with EGF (200ng/ml, 30mins) at 30 µg with immunising peptide

Predicted band size: 124 kDa

Observed band size: 124 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

African green monkey

Applications

WB

applications

Immunogen

Synthetic Peptide within Human RET phospho Y1015. The exact immunogen used to generate this antibody is proprietary information.

P07949

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Mouse": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "" }, "African green monkey": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/1000", "WB-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Purification notes
ab74154 was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using non-phosphopeptide corresponding to the phosphorylation site.
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 50% Glycerol (glycerin, glycerine), 0.87% Sodium chloride
Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Storage information
Stable for 12 months at -20°C

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Ret also known as "rearranged during transfection" is a receptor tyrosine kinase with a mass of approximately 170-175 kDa. Scientists often study Ret because of its key role in cellular signaling pathways. It is primarily expressed in neural crest-derived cells and tissues including the kidneys and the enteric nervous system. Ret is also found in various other cell types throughout the body such as endocrine and hematopoietic tissues.
Biological function summary

The Ret protein facilitates several critical processes within the body. It functions as part of a complex with co-receptors called GFRα (GDNF family receptor alpha) which are required for binding ligands such as GDNF (glial cell line-derived neurotrophic factor). This binding activates downstream signaling pathways that influence cell growth differentiation and survival particularly within the nervous system. The proper functioning of Ret is essential for the development and maintenance of these cellular environments.

Pathways

Ret is an important component of the MAPK/ERK and PI3K/AKT signaling pathways. These pathways mediate various cellular responses including cell proliferation survival and apoptosis. The interactions of Ret with other proteins like SHC and GRB2 within these pathways create ripple effects that impact larger cellular networks. Through these pathways Ret connects with multiple proteins to modulate essential biological processes.

Ret's dysregulation is closely associated with multiple endocrine neoplasia type 2 (MEN2) and Hirschsprung's disease. These conditions arise due to mutations affecting Ret's signaling capabilities. In MEN2 Ret mutations lead to uncontrolled cell growth often resulting in medullary thyroid carcinoma. Hirschsprung's disease on the other hand involves a failure in neural crest cell migration leading to congenital gut motility issues. Researchers explore Ret's interactions with other proteins such as endothelin receptor B (EDNRB) to further understand these diseases.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Receptor tyrosine-protein kinase involved in numerous cellular mechanisms including cell proliferation, neuronal navigation, cell migration, and cell differentiation in response to glia cell line-derived growth family factors (GDNF, NRTN, ARTN, PSPN and GDF15) (PubMed : 20064382, PubMed : 20616503, PubMed : 20702524, PubMed : 21357690, PubMed : 21454698, PubMed : 24560924, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886, PubMed : 31118272). In contrast to most receptor tyrosine kinases, RET requires not only its cognate ligands but also coreceptors, for activation (PubMed : 21994944, PubMed : 23333276, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). GDNF ligands (GDNF, NRTN, ARTN, PSPN and GDF15) first bind their corresponding GDNFR coreceptors (GFRA1, GFRA2, GFRA3, GFRA4 and GFRAL, respectively), triggering RET autophosphorylation and activation, leading to activation of downstream signaling pathways, including the MAPK- and AKT-signaling pathways (PubMed : 21994944, PubMed : 23333276, PubMed : 24560924, PubMed : 25242331, PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). Acts as a dependence receptor via the GDNF-GFRA1 signaling : in the presence of the ligand GDNF in somatotrophs within pituitary, promotes survival and down regulates growth hormone (GH) production, but triggers apoptosis in absence of GDNF (PubMed : 20616503, PubMed : 21994944). Required for the molecular mechanisms orchestration during intestine organogenesis via the ARTN-GFRA3 signaling : involved in the development of enteric nervous system and renal organogenesis during embryonic life, and promotes the formation of Peyer's patch-like structures, a major component of the gut-associated lymphoid tissue (By similarity). Mediates, through interaction with GDF15-receptor GFRAL, GDF15-induced cell-signaling in the brainstem which triggers an aversive response, characterized by nausea, vomiting, and/or loss of appetite in response to various stresses (PubMed : 28846097, PubMed : 28846099, PubMed : 28953886). Modulates cell adhesion via its cleavage by caspase in sympathetic neurons and mediates cell migration in an integrin (e.g. ITGB1 and ITGB3)-dependent manner (PubMed : 20702524, PubMed : 21357690). Also active in the absence of ligand, triggering apoptosis through a mechanism that requires receptor intracellular caspase cleavage (PubMed : 21357690). Triggers the differentiation of rapidly adapting (RA) mechanoreceptors (PubMed : 20064382). Involved in the development of the neural crest (By similarity). Regulates nociceptor survival and size (By similarity). Phosphorylates PTK2/FAK1 (PubMed : 21454698).. Isoform 1. Isoform 1 in complex with GFRAL induces higher activation of MAPK-signaling pathway than isoform 2 in complex with GFRAL.
See full target information RET phospho Y1015

Publications (5)

Recent publications for all applications. Explore the full list and refine your search

JCO precision oncology 7:e2300052 PubMed37535881

2023

D898_E901 Deletion Is Oncogenic, Responds to Selpercatinib, and Treatment Resistance Can Arise Via RET-Independent Mechanisms.

Applications

Unspecified application

Species

Unspecified reactive species

Tommaso Porcelli,Marialuisa Moccia,Maria Angela De Stefano,Raffaele Ambrosio,Ettore Capoluongo,Massimo Santoro,Julien Hadoux,Martin Schlumberger,Francesca Carlomagno,Domenico Salvatore

Nucleic acids research 50:10230-10248 PubMed36124682

2022

Super-enhancer-controlled positive feedback loop BRD4/ERα-RET-ERα promotes ERα-positive breast cancer.

Applications

Unspecified application

Species

Unspecified reactive species

Zao-Zao Zheng,Lin Xia,Guo-Sheng Hu,Jun-Yi Liu,Ya-Hong Hu,Yu-Jie Chen,Jia-Yin Peng,Wen-Juan Zhang,Wen Liu

Oncology reports 44:263-272 PubMed32319659

2020

RET receptor expression and interaction with TRK receptors in neuroblastomas.

Applications

Unspecified application

Species

Unspecified reactive species

Laura H Tetri,Venkatadri Kolla,Rebecca L Golden,Radhika Iyer,Jamie L Croucher,Jee-Hye Choi,Suzanne P Macfarland,Koumudi Naraparaju,Peng Guan,Ferro Nguyen,Krutika S Gaonkar,Pichai Raman,Garrett M Brodeur

Nature communications 9:625 PubMed29434222

2018

A secondary RET mutation in the activation loop conferring resistance to vandetanib.

Applications

Unspecified application

Species

Unspecified reactive species

Takashi Nakaoku,Takashi Kohno,Mitsugu Araki,Seiji Niho,Rakhee Chauhan,Phillip P Knowles,Katsuya Tsuchihara,Shingo Matsumoto,Yoko Shimada,Sachiyo Mimaki,Genichiro Ishii,Hitoshi Ichikawa,Satoru Nagatoishi,Kouhei Tsumoto,Yasushi Okuno,Kiyotaka Yoh,Neil Q McDonald,Koichi Goto

Molecular cell 53:738-51 PubMed24560924

2014

Oncogenic RET kinase domain mutations perturb the autophosphorylation trajectory by enhancing substrate presentation in trans.

Applications

WB

Species

Unspecified reactive species

Iván Plaza-Menacho,Karin Barnouin,Kerry Goodman,Rubén J Martínez-Torres,Annabel Borg,Judith Murray-Rust,Stephane Mouilleron,Phillip Knowles,Neil Q McDonald
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com